ArticleMolecular oncology2023

Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma.

Antonio Mulero-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.